中性粒细胞-淋巴细胞比值预测下肢手术疾病严重程度与结局
该回顾性队列研究从Cerner Health Facts数据库纳入2008-2016年接受下肢开放或腔内手术的3687例住院患者,按跛行、静息痛、组织缺损分组。术前NLR高(≥3.65)与院内死亡(OR 5.4)、心脏并发症(OR 2.9)、截肢(OR 2.5)等不良结局独立相关。
要点
- 术前NLR≥3.65与下肢手术院内死亡、心脏并发症、截肢独立相关。
- NLR随PAD严重程度升高:组织缺损>静息痛>跛行。
- 开放手术术后NLR高于腔内手术(6.8 vs 5.2)。
核心结论
- 术前和术后NLR随PAD疾病严重程度显著升高,支持NLR作为反映全身炎症状态的生物标志物。
- 校正混杂因素后,术前高NLR仍与下肢PAD干预后死亡及其他不良结局强相关。
研究设计与样本
- 回顾性队列研究,数据来自Cerner Health Facts数据库2008-2016年住院患者。
- 共纳入3687例下肢手术患者,其中2183例(59%)行腔内手术,1504例(41%)行开放手术。
- 按疾病严重程度分为跛行、静息痛和组织缺损三组,术前和术后计算NLR。
- 采用χ2分析和多变量logistic回归,ROC曲线确定术前(低<3.65;高≥3.65)和术后(低<5.96;高≥5.96)NLR截断值。
主要发现
- 组织缺损患者NLR(4.89)高于静息痛(4.33)和跛行(3.11),P<.0001。
- 开放手术术后NLR(6.8)高于腔内手术(5.2),P<.0001。
- 白种人跛行比例高于黑人(81.7% vs 72.7%,P<.0001),组织缺损比例低于黑人(12.9% vs 20.9%,P<.0001)。
- 术前高NLR与院内死亡(OR 5.4,95%CI 1.68-17.07)、心脏并发症(OR 2.9,95%CI 1.57-5.40)、截肢(OR 2.5,95%CI 1.65-3.87)、肾衰竭(OR 1.9,95%CI 1.18-2.93)、呼吸并发症(OR 1.7,95%CI 1.09-2.76)和住院时间延长(OR 1.9,95%CI 1.89-3.71)相关。
关键数值与推荐
- 术前NLR截断值:低<3.65,高≥3.65;术后NLR截断值:低<5.96,高≥5.96。
- 术前高NLR与院内死亡OR 5.4(95%CI 1.68-17.07)、心脏并发症OR 2.9(95%CI 1.57-5.40)、截肢OR 2.5(95%CI 1.65-3.87)。
- 术前高NLR与肾衰竭OR 1.9(95%CI 1.18-2.93)、呼吸并发症OR 1.7(95%CI 1.09-2.76)、住院时间延长OR 1.9(95%CI 1.89-3.71)。
临床怎么用
- 术前可计算NLR辅助识别下肢PAD术后高风险患者,高NLR者需加强围手术期监测。
- NLR升高提示全身炎症负荷,可结合疾病严重程度用于个体化风险分层。
局限性
- 原文摘要未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Neutrophil-lymphocyte ratio (NLR) has been associated with inferior outcomes after lower extremity interventions. NLR has been associated with systemic inflammation and atherosclerotic burden. We examined NLR, severity of peripheral artery disease (PAD), and outcomes after endovascular or open surgical procedures. METHODS: Inpatients undergoing lower extremity procedures (2008-2016) were selected from Cerner Health Facts database (Cerner Corporation, North Kansas City, Mo) using International Classification of Diseases, Ninth Revision procedure codes. Disease severity was grouped into claudication, rest pain, and tissue loss. Outcomes were identified using International Classification of Diseases, Ninth Revision codes. NLR was calculated preoperatively and postoperatively. A χ2 analysis and multivariable logistic regression were performed. A receiver operating characteristic curve analysis was used to determine the cutoff for preoperative (low, <3.65; high, ≥3.65) and postoperative (low, <5.96; high, ≥5.96) NLR values. RESULTS: There were 3687 patients evaluated; 2183 (59%) underwent endovascular procedures and 1504 (41%) had open procedures. Compared with black patients, claudication was more frequent in white patients (81.7% vs 72.7%; P < .0001), and tissue loss was less common (12.9% vs 20.9%; P < .0001). NLR values were higher for patients with tissue loss than for patients with rest pain or claudication (4.89, 4.33, and 3.11, respectively; P < .0001). Open procedures were associated with higher postoperative NLR values than endovascular procedures (6.8 vs 5.2; P < .0001). Mean preoperative and postoperative NLR values were greater in patients with more severe PAD. Multivariable analysis demonstrated that preoperative high NLR was strongly associated with in-hospital death (odds ratio [OR], 5.4; 95% confidence interval [CI], 1.68-17.07), cardiac complications (OR, 2.9; 95% CI, 1.57-5.40), amputation (OR, 2.5; 95% CI, 1.65-3.87), renal failure (OR, 1.9; 95% CI, 1.18-2.93), respiratory complications (OR, 1.7; 95% CI, 1.09-2.76), and prolonged length of stay (OR, 1.9; 95% CI, 1.89-3.71). CONCLUSIONS: Preoperative and postoperative NLR significantly increases with disease severity for PAD, providing further evidence of NLR as a biomarker of a patient's systemic inflammatory state. After adjustment for confounders, NLR still remained strongly associated with death and other adverse outcomes after intervention for PAD. Further study of the clinical association of NLR with other vascular disorders, such as symptomatic carotid stenosis and symptomatic and ruptured aortic aneurysmal disease, is planned to guide individualized treatment to prevent stroke or aneurysm rupture.
引用
- Bath J, Smith JB, Kruse RL, et al. Neutrophil-lymphocyte ratio predicts disease severity and outcome after lower extremity procedures. J Vasc Surg. 2019. PMID: 31882318. doi:10.1016/j.jvs.2019.10.094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。